Feasibility of Predicting MCI/AD Using Neuropsychological Tests and Serum β-Amyloid (Q35030392)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21660215%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

title

Feasibility of Predicting MCI/AD Using Neuropsychological Tests and Serum β-Amyloid (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21660215%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21660215%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Michael Mullan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21660215%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Cheryl A Luis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21660215%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Laila Abdullah

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21660215%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Benoit Mouzon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21660215%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Andrew P Keegan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21660215%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Fiona Crawford

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21660215%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

publication date

24 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21660215%20AND%20SRC:MED&resulttype=core&format=json

International journal of Alzheimer's disease

4 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21660215%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21660215%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

786264

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21660215%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 3.0 Unported

4 February 2020

copyright license

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

Ten-year change in plasma amyloid beta levels and late-life cognitive decline

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

Serum Abeta levels as predictors of conversion to mild cognitive impairment/Alzheimer disease in an ADAPT subcohort

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

Forecasting the global burden of Alzheimer’s disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

Early identification and treatment of Alzheimer's disease: social and fiscal outcomes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

Alzheimer's Disease Anti-inflammatory Prevention Trial: design, methods, and baseline results

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

Monitoring the amyloid beta-peptide in vivo--caveat emptor

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

High serum Abeta and vascular risk factors in first-degree relatives of Alzheimer's disease patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

Prodromal Alzheimer's disease: successive emergence of the clinical symptoms

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

Patterns of atrophy differ among specific subtypes of mild cognitive impairment

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

Neuropsychological measures in normal individuals that predict subsequent cognitive decline.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

Current concepts in mild cognitive impairment

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

Dementia diagnoses from clinical and neuropsychological data compared: the Cache County study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

Mild cognitive impairment: clinical characterization and outcome

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

Development and validation of a geriatric depression screening scale: a preliminary report

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

The Modified Mini-Mental State (3MS) examination

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

The development and validation of a test battery for detecting and monitoring everyday memory problems.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

Memory complaint after electroconvulsive therapy: assessment with a new self-rating instrument

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

Predictors of cognitive change in middle-aged and older adults with memory loss

8 July 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F786264

PET of brain amyloid and tau in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F786264

Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F786264

Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F786264

The influence of matrix type, diurnal rhythm and sample collection and processing on the measurement of plasma beta-amyloid isoforms using the INNO-BIA plasma Abeta forms multiplex assay

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F786264

Detection of MCI in the clinic: evaluation of the sensitivity and specificity of a computerised test battery, the Hopkins Verbal Learning Test and the MMSE.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F786264

Serum beta-amyloid correlates with neuropsychological impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F786264

Expanded norms for the Controlled Oral Word Association Test.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F786264

Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F786264

beta-Amyloid is associated with reduced cognitive function in healthy older adults.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109876

Plasma amyloid beta protein is elevated in late-onset Alzheimer disease families

25 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21660215

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The influence of diagnosis, intra- and inter-person variability on serum and plasma Abeta levels

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21660215

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Performance of the dementia severity rating scale: a caregiver questionnaire for rating severity in Alzheimer disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21660215

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4061/2011/786264

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21660215%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21660215%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

PubMed publication ID

21660215

1 reference